Genmab initiating share buy-back program for up to 190,000 shares

Genmab A/S announced that it is initiating a share buy-back program to honor commitments under the company’s Restricted Stock Unit program. The share buy-back program will start on February 15 and end on March 15, unless Genmab terminates or suspends the program. Genmab has appointed Danske Bank as lead manager for the share buy-back program. Danske Bank will make its own trading decisions and act independently of and without influence or involvement from Genmab. Under this share buy-back program Genmab may repurchase up to 190,000 shares. “As of February 14, 2024, Genmab holds 735,891 treasury shares equal to 1.11% of the share capital. Genmab is entitled to suspend or stop the program at any time subject to announcement to Nasdaq Copenhagen. Upon initiation of the program, Genmab will issue a weekly announcement in respect of transactions made under the program,” the company stated.